Metronidazole Use in Malodorous Skin Lesions
- 1 September 1992
- journal article
- Published by Wolters Kluwer Health in Rehabilitation Nursing Journal
- Vol. 17 (5) , 244-245
- https://doi.org/10.1002/j.2048-7940.1992.tb01558.x
Abstract
Malodorous skin lesions (primarily fungating tumors and decubitus ulcers) can be extremely resistant to efforts to control their odors. The offending bacteria appear to be anaerobes, specifically the Bacteroides species. Topical metronidazole has shown promise for odor control without the cost or side effects of a systemic drug. In various anecdotal reports, lesions in patients treated with topical metronidazole were virtually free of odor within 24 hours, and in some cases, slight improvements in wound appearance and pain also were noted. The encouraging results of these initial experiences with topical metronidazole warrant further study for its efficacy in reducing skin lesion odor.Keywords
This publication has 16 references indexed in Scilit:
- Fetor from Ulcerated Head and Neck Tumors: Causation and TherapyAnnals of Otology, Rhinology & Laryngology, 1989
- Anaerobic bacteriaPostgraduate Medicine, 1987
- DOUBLE-BLIND TRIAL OF METRONIDAZOLE IN MALODOROUS ULCERATING TUMOURSThe Lancet, 1984
- Metronidazole dressingsNursing2021, 1982
- METRONIDAZOLE IN SMELLY GYNAECOLOGICAL TUMOURSThe Lancet, 1981
- Malodorous Tumors and MetronidazoleAnnals of Internal Medicine, 1981
- HONEY FOR NECROTIC MALIGNANT BREAST ULCERSThe Lancet, 1980
- CHARCOAL CLOTH AND MALODOROUS WOUNDSThe Lancet, 1980
- METRONIDAZOLE IN SMELLY TUMOURSThe Lancet, 1980
- TREATMENT OF ANAEROBICALLY INFECTED PRESSURE SORES WITH TOPICAL METRONIDAZOLEThe Lancet, 1978